Factors associated with depressive symptoms in African American crack cocaine smokers

Journal of Substance Use

Volumn 14, Issue 3-4, 2009, Pages 161-174

  Schonnesson, L Nilsson ^a   Williams, M ^b   Atkinson, J ^b   Timpson, S ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

African American; Crack cocaine; Depressive symptoms; HIV serostatus

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; ANXIETY; ARTICLE; COCAINE DEPENDENCE; DECISION MAKING; DEPRESSION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRIORITY JOURNAL; SELF ESTEEM; SEX DIFFERENCE; SEXUAL BEHAVIOR;

EID: 69049113141     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.1080/14659890802695857     Document Type: Article

References (40)

1. Alciati, A., Gallo, L., Monforte, A. D., Brambilla, F., & Mellado, C. (2007). Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients. Human Psychopharmacology, 22, 33-40.
2. Baseman, J., Ross, M., & Williams, M. (1999). Sale of sex for drugs and drugs for sex: An economic context of sexual risk behavior for STDs. Sexually Transmitted Diseases, 26, 444-449.
3. Basu, S., Chwastiak, L. A., & Bruce, R. D. (2005). Clinical management of depression and anxiety in HIV-infected adults. AIDS, 19, 2057-2067.
4. Bing, E. G., Burnam, M. A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., & Shapiro, M. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58, 721-728.
5. Boarts, J. M., Sledjeski, E. M., Bogart, L. M., & Delahanty, D. L. (2006). The differential impact of PTSD and depression on HIV disease markers and adherence to HAART in people living with HIV. AIDS and Behavior, 10, 253-261.
6. Chander, G., Himelhoch, S., & Moore, R. D. (2006). Substance abuse and psychiatric disorders in HIV-positive patients. Epidemiology and impact on antiretroviral therapy. Drugs, 66, 769-789.
7. Charney, D. A., Palacios-Boix, J., Negrette, J. C., Dobkin, P. L., & Gill, K. J. (2005). Association between concurrent depression and anxiety and six-month outcome of addiction treatment. Psychiatric Services, 56, 927-933.
8. Ciesla, J. A., & Roberts, J. E. (200l). Meta-analysis of the relationship between HIV infection and risk for depressive disorders. American Journal of Psychiatry, 158, 725-730.
9. Cook, J. A., Grey, D., Burke-Miller, J., Cohen, M. H., Anastos, K., Gandhi, M., Richardson, J., Wilson, T., & Young, M. (2006). Effects of treated and untreated depressive symptoms on highly active antiretroviral therapy use in a US multi-site cohort of HIV-positive women. AIDS Care, 18, 93-100.
10. Crepaz, N., & Marks, G. (2001). Are negative affective states associated with HIV sexual risk behaviors? A meta-analytic review. Health Psychology, 20, 291-299.
11. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR®). (2000). Accessed on October 2008 from Available at: www.dsmivtr.org.
12. Friedman, A. S., Terras, A., Zhu, W., & McCallum, J. (2004). Depression, negative self-image, and suicidal attempts as effects of substance use and substance dependence. Journal of Addictive Diseases, 23, 55-71.
13. Gorman, G. M. (1996-1997). Comorbid depression and anxiety spectrum disorders. Depression and Anxiety, 4, 160-168.
14. Hirschfeld, R. M., & Cross, C. K. (1982). Epidemiology of affective disorders. Archives of General Psychiatry, 39, 35-46.
15. Ichovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P., Boland, R. J., & Moore, J. (2001). Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women. J Am Med Ass, 285, 1466-1474.
16. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on nonadherence to HIV treatment. AIDS Care, 16, 199-211.
17. Isreaelski, D. M., Prentiss, D. E., Lubega, S., Balmas, G., Garcia, P., Muhammad, M., Cummings, S., & Koopman, C. (2007). Psychiatric co-morbidity in vulnerable populations receiving primary care for HIV/ AIDS. AIDS Care, 19, 220-225.
18. Johnson, S. D., Cunningham-Williams, R. M., & Cottler, L. B. (2003). A tripartite of HIV-risk for African American women: The intersection of drug use, violence, and depression. Drug and Alcohol Dependence, 21, 169-175.
19. Jones, D. J., Beach, S. R. H., & Forehand, R., Family Health Project Research Group. (2001). HIV infection and depressive symptoms, an investigation of African American single mothers. AIDS Care, 13 343-350.
20. Knight, K., Holcomb, M., & Simpson, D. D. (1994). TCU psychosocial functioning and motivation scales: Manual on psychometric properties. Institute of Behavioral Research, Texas Christian University, Fort Worth, Texas.
21. Knowlton, A. R., Latkin, C. A., Chung, S. E., Hoover, D. R., Ensminger, M., & Celentano, D. D. (2000). HIV and depressive symptom among low income illicit drug users. AIDS and Behavior, 4, 353-360.
22. Knowlton, A. R., Latkin, C. A., Schroedern, I. J. R., Hoover, D. R., Ensminger, M., & Celentano, D. D. (2001). Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care 13, 549-559.
23. Lecrubier, Y., Dolberg, O. T., Andersen, H. F., & Weiller, E. (2008). Qualitative changes in symptomatology as an effect of treatment with escitalopram in generalized anxiety disorder and major depressive disorder. European Archives of Psychiatry and Clinical Neurosciencei 258, 171-178.
24. Lipsitz, J. D., Williams, J. B., Rabkin, J. G., Remien, R. H., Bradbury, M., el Sadr, W., Goetz, R., Sorrell, S., & Gorman, J. M. (1994). Psychopathology in male and female intravenous drug users with and without HIV infection. American Journal of Psychiatry, 151, 1662-1668.
25. Malbergier, A., & Guerra De Andrade, A. (2001). Depressive disorders and suicide attempts in injecting drug users with and without HIV infection. AIDS Care, 13, 141-150.
26. McCoy, C., & Inciardi, J. (1995). Sex, drugs, and continuing spread of AIDS. Los Angeles, CA: Roxbury.
27. Mizuno, Y., Purcell, D. W., Dawson-Rose, C., & Parsons, J. T., the SUDIS Team. (2003). Correlates of depressive symptoms among HIV-seropositive injection drug users: The role of social support. AIDS Care, 15 689-698.
28. Morrison, M. F., Petitto, J. M., Ten Have, T., Gettes, D. R., Chiappini, M. S., Weber, A. L., Brinker-Spence, P., Bauer, R. M., Douglas, S. D., & Evans, D. L. (2002). Depressive and anxiety disorders in women with HIV infection. American Journal of Psychiatry, 159, 789-796.
29. Myers, M. D., Knight, K., Simpson, D. D., & Stevens, S. (1991). Psychosocial assessments during drug abuse treatment. Presentation at the Southwestern Psychological Association meeting, New Orleans, LA.
30. Piccinelli, M., & Wilkinson, G. (2000). Gender differences in depression. British Journal of Psychiatry, 177, 486-492.
31. Rabkin, J. G., Johnson, J., Lin, S. H., Lipsitz, J. D., Remien, R. H., Williams, J. B. W., & Gorman, J. M. (1997). Psychopathology in male and female HIV-positive and negative injecting drug users: Longitudinal course over 3 years. AIDS, 11, 509-515.
32. Richardson, J., Barkan, S., Cohen, M., Back, S., FitzGerald, G., Feldman, J., Young, M., & Palacio, H. (2001). Experience and covariates of depressive symptoms among a cohort of HIV infected women. Social Work and Health Care, 32, 93-111.
33. Risser, J. M., Timpson, S. C., McCurdy, S. A., Ross, M. W., & Williams, M. L. (2006). Psychological correlates of trading sex for money among African American crack cocaine smokers. American Journal of Drug and Alcohol Abuse, 32, 645-653.
34. Roberts, A. C., Wechsberg, W. M., Zule, W., & Burroughs, A. R. (2003). Contextual factors and other correlates of sexual risk of HIV among African-American crack-abusing women. Addiction Behavior, 28 523-536.
35. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, B. D., Zack, J. A. & Baldwin, G. C. (2002). Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral leukocytes. Journal of Infectious Diseases, 185, 701-705.
36. Simpson, D. D. (1991). Psychosocial measures: Update on TCU/DATAR self-rating scales. Presentation at the Southwest Region NADR Meeting, March 14-15, Dallas, Texas.
37. Turrina, C., Fiorazzo, A., Turano, A., Cacciani, P., Regini, C., Castelli, F., & Sacchetti, E. (2001). Depressive disorders and personality variables in HIV positive and negative intravenous drug-users. Journal of Affective Disorders, 65, 45-53.
38. Williams, C. T., & Latkin, C. A. (2005). The role of depressive symptoms in predicting sex with multiple and high-risk partners. Journal of AIDS, 38, 69-73.
39. Williams, P., Narciso, L., Browne, G., Roberts, J., Weir, R., & Gafni, A. (2005). The prevalence, correlates, and costs of depression in people living with HIV/AIDS in Ontario: Implications for service directions. AIDS Education and Prevention, 17, 119-130.
40. Wisniewski, A. B., Apel, S., Selnes, O. A., Nath, A., McArthur, J., & Dobs, A. S. (2005). Depressive symptoms, quality of life, and neuropsychological performance in HIV/AIDS: The impact of gender and injection drug use. Journal of NeuroVirology, 11, 138-143.